Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NEDD8-MDP1 readthrough refers to a transcript generated by the fusion of the NEDD8 (neural precursor cell expressed, developmentally downregulated 8) gene and MDP1 (magnesium-dependent phosphatase 1), resulting in a protein that combines sequence domains from both parents. This is a naturally occurring phenomenon at the chromosomal locus where these genes are neighbors. The encoded read-through gene appears to be protein coding, with putative phosphatase activity, but it is not established as a conventional or validated therapeutic target, receptor, or enzyme like the canonical NEDD8 or MDP1 proteins[3][5][6]. No established molecular classification as an enzyme, receptor, transporter, or signaling molecule is defined. There is no strong evidence implicating NEDD8-MDP1 readthrough in major disease roles, nor are any biomarkers, drugs, or mechanisms of action associated with targeting this fusion gene. Preliminary annotations relate it primarily to gene expression and protein fusions rather than defined biological or pathological functions. Clarifications: - The target is **not a canonical enzyme, receptor, transporter, or typical drug target**; it is a fusion (read-through) gene. - There is **no evidence of its direct use as a therapeutic target**, nor are there documented drugs or mechanisms of action related to it. - Most database entries primarily annotate the phenomenon of read-through transcription, with very limited functional or disease information[3][5][6]. - This entry is considered **incorrect for standard drug target contexts** because it does not match canonical, actionable biomolecular targets. - There is a risk of conflating the NEDD8-MDP1 readthrough with its parent proteins, which do have distinct biological functions; the read-through itself is not widely characterized as a functional or therapeutic target. If a standard, actionable target is needed, you may want to refer instead to either the canonical NEDD8 protein or the MDP1 protein individually.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NEDD8-MDP1 readthrough transcript (NEDD8-MDP1).